Amgen-partnered AI biotech startup brings in $273M


A biotech startup using generative AI to create new, protein-based medicines has closed on a $273 million round as it looks to expand its reach.

Previous California private equity firm buys Far East Side logistics center
Next U.S. rent prices near a new all-time high. See how Tampa Bay measures up